ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
OmniAb Inc

OmniAb Inc (OABI)

3.715
-0.165
( -4.25% )
Updated: 11:42:22

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
3.715
Bid
3.71
Ask
3.72
Volume
129,948
3.68 Day's Range 3.93
3.56 52 Week Range 6.715
Market Cap
Previous Close
3.88
Open
3.93
Last Trade
100
@
3.715
Last Trade Time
11:42:22
Financial Volume
$ 490,438
VWAP
3.7741
Average Volume (3m)
397,267
Shares Outstanding
118,162,691
Dividend Yield
-
PE Ratio
-8.78
Earnings Per Share (EPS)
-0.43
Revenue
34.16M
Net Profit
-50.62M

About OmniAb Inc

OmniAb Inc offers best-in-class therapeutic antibody discovery technologies. OmniAb Inc offers best-in-class therapeutic antibody discovery technologies.

Sector
Coml Physical, Biologcl Resh
Industry
Blank Checks
Website
Headquarters
Wilmington, Delaware, USA
Founded
2022
OmniAb Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker OABI. The last closing price for OmniAb was $3.88. Over the last year, OmniAb shares have traded in a share price range of $ 3.56 to $ 6.715.

OmniAb currently has 118,162,691 shares outstanding. The market capitalization of OmniAb is $458.47 million. OmniAb has a price to earnings ratio (PE ratio) of -8.78.

OABI Latest News

OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2024, and...

OmniAb to Participate in Two Investor Conferences in November

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two investor conferences during the month of November. Stifel 2024 Healthcare Conference, November 18-19 at...

OmniAb to Report Third Quarter 2024 Financial Results on November 12

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and nine months ended September 30, 2024 after the close of the U.S. financial markets on Tuesday, November 12, 2024 and...

OmniAb to Participate in Two Investor Conferences in September

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two investor conferences during the month of September. H.C. Wainwright 26th Annual Global Investment...

OmniAb Reports Second Quarter 2024 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and six months ended June 30, 2024, and provided...

OmniAb to Report Second Quarter 2024 Financial Results on August 8

OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on Thursday, August 8, 2024 and will hold...

OmniAbが重鎖単一ドメイン抗体ニワトリプラットフォームに関する学術論文を米国免疫学会雑誌に発表

単一ドメイン抗体(sdAb)を産生する遺伝子改変ニワトリが、完全ヒト型安定化sdAbを産生する2023年発表の新規トランスジェニックニワトリプラットフォームOmnidAb™の科学的基盤に (ビジネスワイヤ) -- Omni...

OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology

Engineered chickens producing single domain antibodies (sdAbs) provided the scientific foundation for OmnidAb™, the Company’s novel transgenic chicken platform launched in 2023 that generates...

OmniAb to Participate in the Jefferies Global Healthcare Conference

OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating at the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York...

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit

Technical synergies between xPloration, OmniFlic®, OmniClic® and OmniDeep® enable new bispecific antibody discovery workflows for OmniAb’s partners OmniAb, Inc. (Nasdaq: OABI) today announced its...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.845-18.53070175444.564.613.686565624.1374415CS
4-0.365-8.946078431374.084.843.684479134.19744615CS
12-0.635-14.59770114944.354.843.683972674.21478599CS
26-0.735-16.51685393264.454.963.565117114.25202036CS
52-0.745-16.70403587444.466.7153.565145394.80072366CS
156-1.355-26.72583826435.076.7151.916781824.14424637CS
260-1.355-26.72583826435.076.7151.916781824.14424637CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HCWBHCW Biologics Inc
$ 1.63
(453.29%)
353.67M
APLMApollomics Inc
$ 0.1575
(64.23%)
560.02M
JWELJowell Global Ltd
$ 3.0367
(55.73%)
6.37M
ACRSAclaris Therapeutics Inc
$ 2.94
(43.41%)
10.7M
SINTSiNtx Technologies Inc
$ 2.92
(43.14%)
45.28M
CMAXCareMax Inc
$ 0.724
(-56.90%)
558.2k
QMMMQMMM Holdings Limited
$ 3.51
(-52.11%)
921.12k
NGNENeurogene Inc
$ 20.39
(-40.92%)
844.05k
AILEiLearningEngines Inc
$ 0.9701
(-35.33%)
3.7M
SGDSafe and Green Development Corporation
$ 1.85
(-30.45%)
246.71k
APLMApollomics Inc
$ 0.1575
(64.23%)
565.22M
HCWBHCW Biologics Inc
$ 1.63
(453.29%)
355.43M
ELABElevai Labs Inc
$ 0.0231
(4.52%)
159.72M
NVDANVIDIA Corporation
$ 141.0092
(-0.68%)
101.3M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 21.1117
(12.84%)
68.77M

Your Recent History

Delayed Upgrade Clock